Mesenchymal stem cell therapy for equine tendinitis

Nenhuma Miniatura disponível

Data

2013-03-28

Orientador

Coorientador

Pós-graduação

Curso de graduação

Título da Revista

ISSN da Revista

Título de Volume

Editor

Tipo

Resenha

Direito de acesso

Acesso restrito

Resumo

Tendinitis is an important disease that leads to lameness and decreased performance in equine athletes and results in high costs associated with therapy due to a long recovery period and a high rate of recurrence. Although, several treatments for equine tendinitis have been described, few are effective in significantly improving the quality of the extracellular matrix and reducing the rate of recurrence. The use of cell therapy with mesenchymal stem cells (MSCs) derived from various sources has received much attention because of its therapeutic potential for equine tendinitis. In this paper, we review patents on stem cell therapy and the specific use of MSCs for the treatment of equine tendinitis. © 2013 Bentham Science Publishers.

Descrição

Idioma

Inglês

Como citar

Recent Patents on Regenerative Medicine, v. 3, n. 2, p. 103-110, 2013.

Itens relacionados

Financiadores